HOME >> MEDICINE >> NEWS
UCSF Recruting Breast Cancer Patients For Herbal Therapy Study

Researchers at the University of California San Francisco are recruiting patients for the first study in the U.S. that will determine the feasibility of using Chinese herbal therapy to alleviate the side effects of chemotherapy in women with early stage breast cancer.

Developed in collaboration at UCSF with Western breast cancer investigators and practitioners as well as non-Western herbalists, this study aims to scientifically evaluate the benefits of a Chinese herbal formula that is widely used by herbalists for cancer patients receiving chemotherapy. In addition, the trial will assess any toxicities associated with the use of the formula in conjunction with chemotherapy.

After conferring with many herbalists around the world, studying past clinical trials of herbal therapies, and reading text books on the subject, UCSF researchers developed a formula consisting of a range of herbs that they hope will alleviate multiple side effects of chemotherapy. The formula contains 21 herbs and has received an Investigational New Drug (IND) license from the Food and Drug Administration which is necessary to conduct a clinical trial.

This novel trial is a crucial first step to integrating traditional Chinese medicine, where effective, into the standard of care for breast cancer patients, UCSF researchers said.

"Ultimately, we would like to develop a model in which we integrate the parts of herbal therapies that are safe and effective with those that we know are effective in standard conventional therapy, such as chemotherapy," said Debu Tripathy, MD, UCSF associate professor of medicine, director of clinical research at the UCSF Carol Franc Buck Breast Care Center and principal investigator of the study.

In the U.S., most women are diagnosed with breast cancer at an early stage. Chemotherapy is being recommended more often as studies now show a clear reduction in the risk of cancer spread, Tripathy said. However, he added that the treatm
'"/>

Contact: Abby Sinnott
sinnott@itsa.ucsf.edu
415-885-7277
University of California - San Francisco
27-Oct-1998


Page: 1 2 3

Related medicine news :

1. Hausman to give keynote address at Breastfeeding, Motherhood and Feminism symposium
2. Breast implant Website launched by leading plastic surgery societies
3. Breast cancer treatment reduces risk of heart disease
4. Breast reconstruction with implants after mastectomy doesnt hurt survival chances
5. Breast cancer may be uniquely sensitive to inhibitors of PI3K pathway
6. Breast MRI moderately useful for detecting breast cancer, but does not eliminate need for biopsy
7. Breast conserving therapy safe for hereditary breast cancer
8. Breast cancer risk, prognosis and weight gain reduced with physical activity
9. Breast cancer in Asian Americans is rising faster than in any other ethnic group
10. Long Island Breast Cancer Study data: Aspirin helps protect some women against breast cancer
11. Breast cancer in men increasing

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/17/2017)... ... February 17, 2017 , ... ... services, announced today that Karen Pilley has been promoted to Chief Executive Officer. ... today’s shifting healthcare paradigm – a shift that demands the transition from pay-for-service ...
(Date:2/17/2017)... ... February 17, 2017 , ... Like most hospitals across the nation, Onslow Memorial ... by the Hospital Readmission Reduction Program (HRRP), the return of a patient to the ... across the nation. While many providers are struggling to leverage limited resources and technology, ...
(Date:2/16/2017)... ... February 17, 2017 , ... ... took over 10 years of research, development and clinical trials, the founder of ... is a patented compound of FDA approved ingredients that when infused into alcohol, ...
(Date:2/16/2017)... ... February 16, 2017 , ... ... and superiority in patient care, NWH has achieved Magnet® recognition for ... Tuesday, January 31, 2017. The American Nurses Credentialing Center’s Magnet Recognition Program® distinguishes ...
(Date:2/16/2017)... ... February 16, 2017 , ... A February 6 ... as fat freezing or CoolSculpting, noting that some 425,000 procedures were performed with the ... that the clinic is, in fact, seeing a great deal of interest from area ...
Breaking Medicine News(10 mins):
(Date:2/17/2017)... YORK , Feb. 17, 2017  Noble Capital ... on ESSA Pharma Inc. (Nasdaq: EPIX ). ... Research, Kumar Raja , PhD. ESSA ... for castration resistant prostate cancer (CRPC). Its lead compound ... blocks the amino-terminal domain of the androgen receptor, thereby ...
(Date:2/16/2017)... , Feb. 16, 2017 The global ... USD 7.88 billion by 2021 from USD 5.49 billion ... On the basis of type, the preparative and ... preparative chromatography. In 2016, the process chromatography segment is ... global preparative and process chromatography. Growth in this segment ...
(Date:2/16/2017)... , Feb. 16, 2017  AcelRx Pharmaceuticals, Inc. ... company focused on the development and commercialization of ... pain, announced that Vincent J. Angotti ... member of the company,s board of directors, effective ... two decades of experience leading executive and commercial ...
Breaking Medicine Technology:
Cached News: